• 2020
  Bosc N, Muller C, Hoffer L, Lagorce D, Bourg S, Derviaux C, Gourdel ME, Rain JC, Miller TW, Villoutreix BO, Miteva MA, Bonnet P, Morelli X, Sperandio O, Roche P, Fr-PPIChem: An academic compound library dedicated to protein-protein interactions, ACS Chem. Biol. 2020 Apr;.
• 2017
  Bosc N, Kuenemann MA, Bécot J, Vavrusa M, Cerdan AH, Sperandio O, Privileged Substructures to Modulate Protein-Protein Interactions, J Chem Inf Model 2017 Oct;57(10):2448-2462.
• 2016
  Kuenemann MA, Labbé CM, Cerdan AH, Sperandio O, Imbalance in chemical space: How to facilitate the identification of protein-protein interaction inhibitors, Sci Rep 2016 Apr;6:23815.
• 2015
  Moroy G, Sperandio O, Rielland S, Khemka S, Druart K, Goyal D, Perahia D, Miteva MA, Sampling of conformational ensemble for virtual screening using molecular dynamics simulations and normal mode analysis, Future Med Chem 2015;7(17):2317-31.
• 2015
  Bosc N, Wroblowski B, Aci-Sèche S, Meyer C, Bonnet P, A Proteometric Analysis of Human Kinome: Insight into Discriminant Conformation-dependent Residues, ACS Chem. Biol. 2015 Dec;10(12):2827-40.
• 2015
  Zarzycka B, Kuenemann MA, Miteva MA, Nicolaes GA, Vriend G, Sperandio O, Stabilization of protein-protein interaction complexes through small molecules, Drug Discov. Today 2016 Jan;21(1):48-57.
• 2015
  Labbé CM, Kuenemann MA, Zarzycka B, Vriend G, Nicolaes GA, Lagorce D, Miteva MA, Villoutreix BO, Sperandio O, iPPI-DB: an online database of modulators of protein-protein interactions, Nucleic Acids Res. 2016 Jan;44(D1):D542-7.
• 2015
  Lagorce D, Sperandio O, Baell JB, Miteva MA, Villoutreix BO, FAF-Drugs3: a web server for compound property calculation and chemical library design, Nucleic Acids Res. 2015 Jul;43(W1):W200-7.
• 2015
  Labbé CM, Rey J, Lagorce D, Vavruša M, Becot J, Sperandio O, Villoutreix BO, Tufféry P, Miteva MA, MTiOpenScreen: a web server for structure-based virtual screening, Nucleic Acids Res. 2015 Jul;43(W1):W448-54.
• 2015
  Sperandio O, Villoutreix BO, Morelli X, Roche P, [Chemical libraries dedicated to protein-protein interactions], Med Sci (Paris) 2015 Mar;31(3):312-9.
• 2015
  Kuenemann MA, Sperandio O, Labbé CM, Lagorce D, Miteva MA, Villoutreix BO, In silico design of low molecular weight protein-protein interaction inhibitors: Overall concept and recent advances, Prog. Biophys. Mol. Biol. 2015 Oct;119(1):20-32.
• 2014
  Kuenemann MA, Bourbon LM, Labbé CM, Villoutreix BO, Sperandio O, Which three-dimensional characteristics make efficient inhibitors of protein-protein interactions?, J Chem Inf Model 2014 Nov;54(11):3067-79.
• 2014
  Villoutreix BO, Kuenemann MA, Poyet JL, Bruzzoni-Giovanelli H, Labbé C, Lagorce D, Sperandio O, Miteva MA, Drug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology, Mol Inform 2014 Jun;33(6-7):414-437.
• 2014
  Villemagne B, Flipo M, Blondiaux N, Crauste C, Malaquin S, Leroux F, Piveteau C, Villeret V, Brodin P, Villoutreix BO, Sperandio O, Soror SH, Wohlkönig A, Wintjens R, Deprez B, Baulard AR, Willand N, Ligand efficiency driven design of new inhibitors of Mycobacterium tuberculosis transcriptional repressor EthR using fragment growing, merging, and linking approaches, J. Med. Chem. 2014 Jun;57(11):4876-88.
• 2014
  Mathieu AL, Sperandio O, Pottiez V, Balzarin S, Herlédan A, Elkaïm JO, Fogeron ML, Piveteau C, Dassonneville S, Deprez B, Villoutreix BO, Bonnefoy N, Leroux F, Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737, J Biomol Screen 2014 Aug;19(7):1035-46.
• 2014
  Charton J, Gauriot M, Guo Q, Hennuyer N, Marechal X, Dumont J, Hamdane M, Pottiez V, Landry V, Sperandio O, Flipo M, Buee L, Staels B, Leroux F, Tang WJ, Deprez B, Deprez-Poulain R, Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis, Eur J Med Chem 2014 May;79:184-93.
• 2014
  Sperandio O, Wildhagen KC, Schrijver R, Wielders S, Villoutreix BO, Nicolaes GA, Identification of novel small molecule inhibitors of activated protein C, Thromb. Res. 2014 Jun;133(6):1105-14.
• 2013
  Nicolaes GA, Kulharia M, Voorberg J, Kaijen PH, Wroblewska A, Wielders S, Schrijver R, Sperandio O, Villoutreix BO, Rational design of small molecules targeting the C2 domain of coagulation factor VIII, Blood 2014 Jan;123(1):113-20.
• 2013
  Maingot L, Elbakali J, Dumont J, Bosc D, Cousaert N, Urban A, Deglane G, Villoutreix B, Nagase H, Sperandio O, Leroux F, Deprez B, Deprez-Poulain R, Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding group, Eur J Med Chem 2013 Nov;69:244-61.
• 2013
  Villoutreix BO, Lagorce D, Labbé CM, Sperandio O, Miteva MA, One hundred thousand mouse clicks down the road: selected online resources supporting drug discovery collected over a decade, Drug Discov. Today 2013 Nov;18(21-22):1081-9.
• 2013
  Pérot S, Regad L, Reynès C, Spérandio O, Miteva MA, Villoutreix BO, Camproux AC, Insights into an original pocket-ligand pair classification: a promising tool for ligand profile prediction, PLoS ONE 2013;8(6):e63730.
• 2013
  Isvoran A, Craciun D, Martiny V, Sperandio O, Miteva MA, Computational analysis of protein-protein interfaces involving an alpha helix: insights for terphenyl-like molecules binding, BMC Pharmacol Toxicol 2013 Jun;14:31.
• 2013
  Labbé CM, Laconde G, Kuenemann MA, Villoutreix BO, Sperandio O, iPPI-DB: a manually curated and interactive database of small non-peptide inhibitors of protein-protein interactions, Drug Discov. Today 2013 Oct;18(19-20):958-68.